보조생식기술(ART) 시장 규모는 2023년 359억 2,000만 달러로 평가되었고, 예측 기간(2025-2032년) 동안 8.3%의 연평균 복합 성장률(CAGR)로 2024년 389억 9,000만 달러에서 2032년 736억 2,000만 달러로 성장할 것으로 예측됩니다.
불임률 증가, 불임 치료 및 대리모에 대한 인식이 높아짐에 따라 세계 보조생식술(ART) 시장은 크게 성장하고 있으며, 체외수정(IVF)과 대리모 등 개인과 부부의 임신을 돕기 위해 고안된 다양한 방법을 포함하고 있습니다. 세계보건기구(WHO)는 2020년까지 약 4,800만 쌍의 부부와 1억 8,600만 명의 개인이 불임 진단을 받을 것으로 추정하고 있어 이러한 서비스의 필요성을 강조하고 있습니다. 또한, 질병통제예방센터는 PCOS를 가진 미국 여성의 6%에서 12%까지 불임으로 고통받고 있다고 강조하며 그 수요를 더욱 증가시키고 있습니다. 공공 및 민간 부문의 재정적 지원과 지속적인 기술 발전으로 ART 시장의 미래는 여전히 견고합니다.
Assisted Reproductive Technology Market size was valued at USD 35.92 billion in 2023 and is poised to grow from USD 38.9 billion in 2024 to USD 73.62 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).
The global market for Assisted Reproductive Technology (ART) is experiencing significant growth due to rising infertility rates and increased awareness of fertility treatments and surrogacy. ART encompasses a range of methods including in vitro fertilization (IVF) and gestational surrogacy, designed to assist individuals and couples in conceiving. The World Health Organization estimates that in 2020, approximately 48 million couples and 186 million individuals faced infertility diagnoses, emphasizing the scale of the need for these services. Additionally, the Centers for Disease Control and Prevention highlight that 6% to 12% of American women with PCOS also struggle with infertility, further propelling demand. With funding from both public and private sectors and ongoing technological advancements, the ART market's prospects remain robust.
Top-down and bottom-up approaches were used to estimate and validate the size of the Assisted Reproductive Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Assisted Reproductive Technology Market Segments Analysis
Global Assisted Reproductive Technology Market is segmented by Type, End-Use and region. Based on Type, the market is segmented into In-Vitro Fertilization (IVF), Artificial Insemination and Others. Based on End-Use, the market is segmented into Fertility Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Assisted Reproductive Technology Market
The rise in infertility rates, driven by factors like delayed childbirth, lifestyle modifications, and environmental influences, underscores the growing importance of Assisted Reproductive Technology (ART). As more couples seek solutions for their infertility issues, there is a corresponding increase in demand for ART services. This heightened interest not only highlights the need for viable reproductive options but also propels the growth of the ART industry, making it a vital component of modern reproductive health solutions. Consequently, the trend indicates a significant expansion potential for ART, reflecting society's evolving approach to family building in the face of fertility challenges.
Restraints in the Assisted Reproductive Technology Market
One of the primary challenges facing the Assisted Reproductive Technology (ART) market is the high cost associated with treatments such as in vitro fertilization (IVF) and other related procedures. These substantial expenses can limit accessibility and affordability for many patients, ultimately hindering the overall growth of the market, especially in areas that lack robust healthcare infrastructure. As a result, the financial burden can prevent individuals from seeking necessary ART services, thereby stifling market expansion in regions where the demand for such technologies exists but is unmet due to prohibitive costs.
Market Trends of the Assisted Reproductive Technology Market
The Assisted Reproductive Technology (ART) market is witnessing a significant trend towards the expansion of personalized solutions, bolstered by advancements in genetic screening and embryo analysis. This shift towards individualized ART therapies is driven by the desire to enhance overall success rates and optimize treatment efficiency. By addressing specific causes of infertility and tailoring approaches to meet individual patient needs, healthcare providers can offer more targeted and effective fertility treatments. As a result, this trend not only improves patient outcomes but also fosters continued innovation in the reproductive health sector, reflecting an evolving landscape that prioritizes personalized care.